Lancet Market Size Worth USD 3.72 Billion by 2032 | CAGR 10.63% – Global Forecast 2024–2032
The global Lancet Market was valued at USD 1.5 billion in 2023 and is projected to reach USD 3.72 billion by 2032, growing at a CAGR of 10.63% from 2024 to 2032. This growth is driven by the rising global prevalence of diabetes, increasing adoption of self-monitoring practices, and advancements in pain-free and safety lancet technologies. The market is also benefiting from the expansion of point-of-care testing, the rise of home diagnostics, and growing access to healthcare in emerging economies.